MULTI BARRIER REVERSE CONVERTIBLE - SANOFI/BAYER/JOHNSON & JOHNSON/PFIZER INC Share Price

Certificat

UNOLTQ

CH1194699547

Delayed Swiss Exchange 09:50:00 17/11/2023 pm IST
62.54 CHF +0.06% Intraday chart for MULTI BARRIER REVERSE CONVERTIBLE - SANOFI/BAYER/JOHNSON & JOHNSON/PFIZER INC
1 month-18.93%
3 months-31.49%

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying SANOFI
Issuer LEONTEQ
UNOLTQ
ISINCH1194699547
Date issued 01/07/2022
Strike 97.52
Maturity 01/07/2024 (55 Days)
Parity 1 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 100.1 CHF
Lowest since issue 61.61 CHF

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
91.88 EUR
Average target price
108.1 EUR
Spread / Average Target
+17.61%
Consensus
  1. Stock Market
  2. Certificates
  3. UNOLTQ Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW